Insider Transactions in Q4 2021 at Regenxbio Inc. (RGNX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Olivier Danos Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.01%
|
$27
$27.8 P/Share
|
|
Dec 23
2021
|
Allan M. Fox |
SELL
Open market or private sale
|
Indirect |
51,231
-1.63%
|
$1,793,085
$35.38 P/Share
|
|
Dec 22
2021
|
Allan M. Fox |
SELL
Open market or private sale
|
Indirect |
61,638
-3.75%
|
$2,095,692
$34.4 P/Share
|
|
Dec 02
2021
|
Kenneth T. Mills |
SELL
Bona fide gift
|
Direct |
3,300
-1.17%
|
-
|
|
Nov 08
2021
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct |
1,500
-0.53%
|
$60,000
$40.0 P/Share
|
|
Nov 08
2021
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+0.53%
|
$4,500
$3.76 P/Share
|